Cannabis-based medicines have been gaining attention worldwide, yet in the UK, NHS prescribing remains rare. For many — including former elite athletes like those connected through the Arsenal alumni network and players' unions such as the PFA — understanding why these treatments aren't widely accessible is vital. This blog aims to break down the reasons behind the scarcity of NHS cannabis prescriptions, especially in relation to the challenges surrounding retirement from professional sport.
What the Rule Says: NHS Guidelines on Cannabis-Based Medicines in the UK
Since November 2018, cannabis-based products for medicinal use have been legal to prescribe on the NHS, but only under very specific conditions. The National Institute for Health and Care Excellence (NICE) guidelines state that cannabis-based medicines should be how to get academy coaching jobs prescribed only when other licensed treatment options have been exhausted.
- Prescription is limited to severe, treatment-resistant epilepsy, spasticity in multiple sclerosis, or chemotherapy-induced nausea and vomiting. Specialist clinics or consultants must lead treatment initiation. GPs rarely prescribe these medicines due to limited training and concerns about misuse, cost, and monitoring.
This sets a high bar: while legal, NHS cannabis prescribing is controlled, cautious, and limited to narrow patient groups.
What Happens in Practice?
In practice, NHS prescribing of cannabis-based medicines is rare. Many patients who might benefit find it difficult to access these medications. This is particularly true for retired professional athletes who face complex health challenges linked to their careers but do not meet the narrow criteria set out in guidelines.
Specialist clinics, which have the expertise to prescribe cannabis-based medicines, are unevenly distributed across the UK. Appointment waiting times and referral barriers add further hurdles for those seeking this treatment.
Retirement Shock and Loss of Structure: A Hidden Barrier to Care
For elite athletes, especially footballers transitioning out of professional sport, the end of a career can be jolting. The weekly rhythm, camaraderie, and clear goals suddenly evaporate. According to stories from alumni like those in Arsenal’s network, many face a “retirement shock” — a phenomenon marked by confusion, loss of identity, and uncertainty about the future.
- Loss of daily structure can worsen chronic pain and mental health struggles. Appetite for comprehensive healthcare, including alternative options like cannabis-based medicines, often takes a back seat amid adjustment stress. The PFA actively supports retired players through education and welfare programs, yet gaps remain between need and access.
This shift in identity and structure influences how retired athletes seek care and engage with the NHS system that governs prescribing.
Identity Shift After Elite Sport: Why Does It Matter for Healthcare?
An athlete’s identity is deeply linked to their sport, performance, and social environment. When that is removed, many experience psychological and physical challenges that don’t always fit neatly into diagnostic boxes. Healthcare professionals might see lingering pain, anxiety, or sleep problems — but cannabis-based medicines aren’t a standard recommendation.
The pain clinic vs physiotherapy lack of formal pathways between elite sport environments and NHS specialist clinics compounds the issue. Many retired footballers lack clear information about alternative medicine options that might improve their quality of life.
Role of the PFA and Player Welfare
The Professional Footballers’ Association (PFA) has recognized that planning for life after sport must include both career retraining and health education. They emphasize holistic well-being, including mental health and pain management, but also note a cautious approach to cannabis-based therapies due to limited evidence and unfamiliarity among medical professionals.
Career Pathways and Entry Costs: Barriers Beyond Medicine
Even for retired players interested in exploring cannabis-based medicines, access involves indirect “costs.” These include:
Specialist Referral: Access to a specialist consultant or clinic authorized to prescribe cannabis-based medicines, which often requires navigating NHS waitlists. Travel and Time: Specialist centers might be far from the patient’s home, adding logistical burdens. Financial Considerations: While NHS prescriptions are free at the point of use, private prescriptions for cannabis-based medicines are expensive and thus out of reach for many.These hurdles mean that those without resources, or without guidance on navigating NHS specialist pathways, may never reach proper assessment.
Retraining Before Retirement: Planning Ahead to Bridge the Gap
One of the PFA’s key initiatives focuses on retraining players for second careers — something many athletes do not consider until forced by injury or retirement. This applies not just to finances but health literacy as well.
Planning for retirement should include learning about the healthcare system’s capabilities and limitations. Retired athletes who understand:
- Which conditions cannabis-based medicines might realistically treat The process to access specialist NHS clinics How to communicate health needs effectively with GPs and specialists
are better positioned to advocate for their health and explore emerging treatments responsibly.
Summary Table: Why NHS Prescribing for Cannabis-Based Medicines is Still Rare
Factor Details Impact on Access Strict NICE Guidelines Use restricted to specific conditions; only specialists can initiate Limits numbers of eligible patients Limited Specialist Clinics Uneven geographic distribution, long wait times Delays access; some areas underserved Retirement Shock & Identity Shift Loss of routine and identity impacts healthcare engagement Less focus on complex or alternative treatments Entry Costs (Time, Travel, Referral) Significant logistical and sometimes financial barriers Some never reach assessment phase Lack of Pre-Retirement Health Education Few plans for healthcare navigation after sport ends Reduced awareness and delayed treatment seekingConclusion: Why “Rare” Doesn’t Mean “Impossible”
NHS prescribing of cannabis-based medicines remains rare due to a combination of strict clinical guidelines, limited specialist services, and systemic barriers — intensified by the unique challenges faced by athletes retiring from elite sport. However, programs run by organizations like the PFA and networks such as Arsenal’s alumni community highlight the importance of preparation, education, and advocacy.
For those affected, understanding what the rule says versus what happens in practice is the first step. Recognizing the shortage of clear career and healthcare pathways during the transition out of professional sport can help us push for better welfare support and wider access to innovative therapies in the future.
If you are an athlete or former athlete considering cannabis-based medicines, seek advice from your club’s welfare officer, the PFA, or NHS specialists. Health is personal — what works for one may not work for another — so avoid miracle-cure promises and focus on planning, evidence, and trusted professional guidance.
```